The COVID-19 pandemic has left lasting respiratory consequences for many patients, even months after resolution of acute infection. Individuals recovering from severe cases often experience fatigue, breathlessness, reduced exercise capacity, and radiographic abnormalities that reflect structural lung changes. Persistent inflammation, fibrosis, or vascular damage may underlie these symptoms, raising concerns about long-term respiratory impairment. Early evaluation through pulmonary function tests, imaging, and clinical monitoring is important to identify those at risk of chronic complications. Rehabilitation programs are increasingly being designed to address both the physical and psychological challenges of recovery.
Approaches to post-COVID lung recovery involve multidisciplinary collaboration, blending respiratory therapy, rehabilitation medicine, nutrition, and psychological support. Pulmonary rehabilitation plays a central role in improving lung mechanics, while gradual exercise programs help restore stamina. Anti-fibrotic therapies and novel pharmacologic agents are being investigated for patients showing progressive scarring. Vaccination and preventive care against secondary infections are vital in protecting already vulnerable lungs. Equally important is patient education, guiding individuals on breathing exercises, infection avoidance, and lifestyle changes that enhance lung health. The growing body of research into immune dysregulation, microvascular injury, and repair mechanisms is shaping more tailored strategies. By prioritizing holistic recovery, clinicians aim not only to restore respiratory function but also to improve quality of life after serious illness.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation